Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

Ann Hematol. 2023 May;102(5):1269-1270. doi: 10.1007/s00277-023-05163-z. Epub 2023 Mar 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • B-Cell Maturation Antigen
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Multiple Myeloma* / complications
  • Multiple Myeloma* / therapy
  • Receptors, Chimeric Antigen*
  • Xenograft Model Antitumor Assays

Substances

  • B-Cell Maturation Antigen
  • Receptors, Chimeric Antigen
  • TNFRSF17 protein, human